Hollow mesoporous silica nanoparticles fabrication for anticancer drug delivery

Ngoc Tram Nguyen Thi; Dai Hai Nguyen

doi:10.15625/2525-2518/58/1/14267

Author affiliations

Authors

Ngoc Tram Nguyen Thi Graduate University of Science and Technology, 18 Hoang Quoc Viet, Cau Giay, Ha Noi, Viet Nam
Dai Hai Nguyen Graduate University of Science and Technology, 18 Hoang Quoc Viet, Cau Giay, Ha Noi, Viet Nam

DOI:

https://doi.org/10.15625/2525-2518/58/1/14267

Keywords:

hollow mesoporous silica nanoparticles, silica, biomedicine

Abstract

Mesoporous silica nanoparticles (MSNs) have attracted significant attention from researchers thanks to their high surface area and pore volume, which can increase drug loading capacity. Moreover, MSNs, with their biocompatibility and ease of surface functionalization, are seen as potential drug delivery system. However, the loading of drug into MSNs system still needs further improvement. In this study, hollow mesoporous silica nanoparticles (HMSNs) were fabricated in order to increase the drug loading capacity of nanosilica materials. The synthesized HMSNs possessed inner hollow cores that could remarkably raise the total pore volume and thus improve the capacity for cargo loading. HMSNs were synthesized according to the hard-template method with three main steps: (1) forming of solid SiO2 nanoparticles as templates, (2) forming of core-shell structure by coating MSN layers onto the templates, and (3) forming of hollow core structure by etching away the solid template. The HMSNs product was characterized by TEM, XRD, TGA and FTIR. In addition, drug loading capacity of the material was evaluated with doxorubicin as model drug. The results indicated remarkable improvement in drug loading capacity, compared to MSN sample. Cell assays on cancer lines showed high biocompatibility. These results demonstrated the potential of HMSNs in the delivery of anticancer agents.

Downloads

Download data is not yet available.

References

Iwamoto, T., Clinical application of drug delivery systems in cancer chemotherapy: review of the efficacy and side effects of approved drugs. Biological and Pharmaceutical Bulletin, 2013. 36(5): p. 715-718.

Nguyen, D.H., et al., Targeted doxorubicin nanotherapy strongly suppressing growth of multidrug resistant tumor in mice. International journal of pharmaceutics, 2015. 495(1): p. 329-335.

Nguyen, D.H., et al., Targeting ligand-functionalized and redox-sensitive heparin-Pluronic nanogels for intracellular protein delivery. Biomedical Materials, 2011. 6(5): p. 055004.

Wang, T., et al., Uniform hollow mesoporous silica nanocages for drug delivery in vitro and in vivo for liver cancer therapy. Journal of Materials Chemistry, 2011. 21(14): p. 5299-5306.

Vivero-Escoto, J.L., B.G. Trewyn, and V.S.-Y. Lin, Mesoporous silica nanoparticles: Synthesis and applications, in Annual Review of Nano Research. 2010, World Scientific. p. 191-231.

Li, D., et al., Effect of the addition of 3-glycidoxypropyltrimethoxysilane to tetraethoxyorthosilicate-based stone protective coating using n-octylamine as a catalyst. Bulletin of Materials Science, 2015. 38(1): p. 49-55.

Tang, L. and J. Cheng, Nonporous silica nanoparticles for nanomedicine application. Nano today, 2013. 8(3): p. 290-312.

Li, Y. and J. Shi, Hollow‐structured mesoporous materials: chemical synthesis, functionalization and applications. Advanced Materials, 2014. 26(20): p. 3176-3205.

Fang, X., et al., A cationic surfactant assisted selective etching strategy to hollow mesoporous silica spheres. Nanoscale, 2011. 3(4): p. 1632-1639.

Chen, Y., et al., Hollow/rattle-type mesoporous nanostructures by a structural difference-based selective etching strategy. ACS nano, 2009. 4(1): p. 529-539.

Wu, S., X. Huang, and X. Du, pH-and redox-triggered synergistic controlled release of a ZnO-gated hollow mesoporous silica drug delivery system. Journal of Materials Chemistry B, 2015. 3(7): p. 1426-1432.